Brain Network Changes Underlying Non-motor Symptoms in Amyotrophic Lateral Sclerosis: A Multimodal MRI Perspective

Authors

  • Yihan Jiang
  • Ziyi An
  • Xinying Jiang
  • Yuxin Wen
  • Yuejiang Guo
  • Wanting Xu
  • Miaomiao Wang

DOI:

https://doi.org/10.54097/fy0qrt39

Keywords:

ALS, non-motor symptoms, multimodal MRI, brain network

Abstract

Amyotrophic lateral sclerosis (ALS) has evolved in clinical understanding from an isolated motor neuron disease into a complex multisystem disorder. Current evidence firmly establishes cognitive deficits and behavioral dysfunctions as inherent, non-motor elements of ALS, factors that drastically alter clinical outcomes, life expectancy, and caregiver stress. In light of this growing recognition, multimodal magnetic resonance imaging (MRI) has emerged as a crucial tool for elucidating the multiscale neuropathology of these symptoms, capturing a trajectory from structural damage to functional reorganization. Current findings demonstrate that atrophy in frontotemporal and subcortical regions, coupled with microstructural degradation in the corpus callosum and limbic white matter tracts, underpins deficits in executive function, social cognition, and emotional regulation. Resting-state functional MRI further reveals extensive network reorganization (primarily involving the default mode, frontoparietal control, and ventral attention networks) that appears to evolve from early compensatory hyperconnectivity to late-stage decompensation. More recently, the integration of multimodal data with predictive modeling has advanced the field toward individualized patient stratification and the early detection of cognitive decline. Operating under the premise that non-motor symptoms in ALS are clinical manifestations of widespread brain network degeneration, this review synthesizes recent advances in multimodal MRI. We highlight the structural basis, functional mechanisms, and individual variability of these symptoms, and discuss the translational potential of neuroimaging biomarkers in clinical practice.

Downloads

Download data is not yet available.

References

[1] Feldman EL, Goutman SA, Petri S, et al. Amyotrophic lateral sclerosis. The Lancet. 2022; 400(10360):1363-1380. doi:10.1016/S0140-6736(22)01272-7

[2] Dadon-Nachum M, Melamed E, Offen D. The “Dying-Back” Phenomenon of Motor Neurons in ALS. J Mol Neurosci. 2011; 43(3):470-477. doi:10.1007/s12031-010-9467-1

[3] Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002; 59(7):1077-1079. doi:10.1212/WNL.59.7.1077

[4] Schulthess I, Gorges M, Müller HP, et al. Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis. Sci Rep. 2016; 6(1):38391. doi:10.1038/srep38391

[5] Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K. Amyotrophic lateral sclerosis—a model of corticofugal axonal spread. Nat Rev Neurol. 2013;9(12):708-714. doi:10.1038/nrneurol.2013.221

[6] Jellinger KA. The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update. Int J Mol Sci. 2023; 24(19):14647. doi:10.3390/ijms241914647

[7] Bersano E, Manera U, Huynh W. Editorial: Cognitive and Behavioral Features in ALS: Beyond Motor Impairment in ALS-FTD Spectrum Disorders. Front Neurol. 2022; 13. doi:10.3389/fneur.2022.891841

[8] Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6(11):994-1003. doi:10.1016/S1474-4422(07)70265-X

[9] Burke T, Pinto-Grau M, Lonergan K, et al. Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study. PLOS ONE. 2016; 11(8):e0160850. doi:10.1371/journal.pone.0160850

[10] Chiò A, Moglia C, Canosa A, et al. ALS phenotype is influenced by age, sex, and genetics. Neurology. 2020; 94(8):e802-e810. doi:10.1212/WNL.0000000000008869

[11] De Vocht J, Costello E, McHutchison C, et al. Prioritizing neuropsychological research and care in Amyotrophic Lateral Sclerosis (ALS): building an international neuropsychological framework for ALS. Amyotroph Lateral Scler Front Degener. 2026; 0(0):1-4. doi:10.1080/21678421.2025.2610290

[12] Chiò A, Moglia C, Canosa A, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019; 93(10). doi:10.1212/WNL.0000000000008063

[13] Borgheai SB, Achorn BE, Zisk AH, et al. A Comprehensive Overview of Neurophysiological Correlates of Cognitive Impairment in Amyotrophic Lateral Sclerosis. Cells. 2026; 15(1):37. doi:10.3390/cells15010037

[14] Ghaderi S, Mohammadi S, Fatehi F. Magnetic Resonance Neuroimaging in Amyotrophic Lateral Sclerosis: A Comprehensive Umbrella Review of 18 Studies. Brain Sci. 2025; 15(7):715. doi:10.3390/brainsci15070715

[15] Chen HJ, Zhan C, Cai LM, et al. White matter microstructural impairments in amyotrophic lateral sclerosis: A mean apparent propagator MRI study. NeuroImage Clin. 2021; 32:102863. doi:10.1016/j.nicl.2021.102863

Downloads

Published

30-04-2026

Issue

Section

Articles